On Tuesday, Taysha Gene Therapies Inc (TSHA) stock saw a modest uptick, ending the day at $2.01 which represents a slight increase of $0.03 or 1.52% from the prior close of $1.98. The stock opened at ...
Thierry Bordet, CSO of PulseSight Therapeutics, said, “EVER attracts top European researchers and the most innovative industry players, and I am delighted that we have been accepted to present our ...
Gene Park is a reporter for The Washington Post, covering video games and gaming culture. He joined The Post in 2015 as audience editor, and is a former reporter in the West Coast and Pacific region.